Faeth Therapeutics, Inc. SEC filings FTH

Faeth Therapeutics, Inc. has 452 filings in SEC EDGAR's recent list, going back to Nov 12, 2020. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K/A Amended annual report Jun 2, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 27, 2026 Dec 31, 2025
10-K Annual report Mar 30, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 11, 2025 Dec 31, 2024
10-K Annual report Mar 28, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
10-K Annual report Feb 29, 2024 Dec 31, 2023
ARS Annual report to shareholders Jun 15, 2023 Dec 31, 2022
10-K/A Amended annual report May 1, 2023 Dec 31, 2022
10-K Annual report Mar 29, 2023 Dec 31, 2022
10-K Annual report Mar 15, 2022 Dec 31, 2021
10-K Annual report Mar 30, 2021 Dec 31, 2020

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
FTH (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Austin, TX
SEC filer status
, Emerging growth company
SEC CIK
1829802
Former names
Sensei Biotherapeutics, Inc. (until Jun 16, 2026)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.